Quest Diagnostics Incorporated

NYSE DGX

Quest Diagnostics Incorporated EBITDA Margin for the Trailing 12 Months (TTM) ending December 31, 2024: 17.72%

Quest Diagnostics Incorporated EBITDA Margin is 17.72% for the Trailing 12 Months (TTM) ending December 31, 2024, a -5.36% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Quest Diagnostics Incorporated EBITDA Margin for the Trailing 12 Months (TTM) ending December 31, 2023 was 18.72%, a 1.77% change year over year.
Quest Diagnostics Incorporated EBITDA Margin for the Trailing 12 Months (TTM) ending December 31, 2022 was 18.40%, a -37.18% change year over year.
Quest Diagnostics Incorporated EBITDA Margin for the Trailing 12 Months (TTM) ending December 31, 2021 was 29.28%, a 14.62% change year over year.
Quest Diagnostics Incorporated EBITDA Margin for the Trailing 12 Months (TTM) ending December 31, 2020 was 25.55%, a 24.53% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

NYSE: DGX

Quest Diagnostics Incorporated

CEO	Mr. James E. Davis
IPO Date	Dec. 17, 1996
Location	United States
Headquarters	500 Plaza Drive
Employees	50,000
Sector	Healthcare
Industries Telehealth Biotechnology Clinical Trials Drugstores & Retail Pharmacies Health Insurance & Plans Insurance Medical Instruments Pharmaceuticals

Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Key trends

Past 5 years